Marker Therapeutics, Inc.
(NASDAQ : MRKR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.55%183.950.0%$893.33m
AMGNAmgen, Inc. -0.11%245.991.5%$591.40m
NVAXNovavax, Inc. -1.09%59.6275.7%$456.84m
VRTXVertex Pharmaceuticals, Inc. 0.87%290.531.9%$423.52m
GILDGilead Sciences, Inc. 0.05%61.121.0%$372.47m
REGNRegeneron Pharmaceuticals, Inc. 1.93%625.432.6%$351.08m
SNSSSunesis Pharmaceuticals, Inc. 3.54%4.010.7%$280.31m
ILMNIllumina, Inc. 1.92%228.073.3%$246.17m
BIIBBiogen, Inc. 1.08%220.561.8%$203.41m
GOVXGeoVax Labs, Inc. -4.35%3.080.0%$153.44m
BNTXBioNTech SE -8.08%168.310.0%$140.92m
CRSPCRISPR Therapeutics AG 1.35%82.500.6%$134.56m
RYTMRhythm Pharmaceuticals, Inc. 13.69%23.010.0%$103.79m
MRTXMirati Therapeutics, Inc. 9.06%94.411.6%$102.00m
BMRNBioMarin Pharmaceutical, Inc. 0.94%96.734.2%$96.24m

Company Profile

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.